Evidence map›Paper›PMID 41994779›Full record

ArticleCureus2026

Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Negative Statin-Induced Necrotizing Myopathy: A Challenging Case.

Alexander S Kaiteris, Rahul Tripathi, George Ayob, Brandon Ng

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexander S KaiterisInternal Medicine, Stony Brook University Hospital, Stony Brook, USA.
Rahul TripathiInternal Medicine, Stony Brook University Hospital, Stony Brook, USA.
George AyobInternal Medicine, Stony Brook University Hospital, Stony Brook, USA.
Brandon NgInternal Medicine, Stony Brook University Hospital, Stony Brook, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case of a man in his early 70s who presented to the emergency department with two weeks of diffuse muscle weakness and dark-colored urine. His history of present illness was negative for obvious inciting events based on the admission history and physical exam. Laboratory tests in the emergency department (ED) showed evidence of end-organ dysfunction, including elevated liver enzymes with aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels of 1,197 and 1,718 IU/L, respectively, an elevated creatinine (Cr) level of 1.44 mg/dL, and significant muscle injury indicated by a creatine phosphokinase (CPK) level of 20,000 IU/L. An unspecified myopathy was high on the differential. Workup was negative for autoimmune or rheumatologic causes of myositis, and statin-induced necrotizing myopathy became the top differential. The patient was treated with pulse-dose steroids. His hospital course was complicated by acute kidney failure requiring dialysis, with eventual recovery of kidney function and normalization of clinical and laboratory findings.

Indexed as

acute kidney injuryacute myositismuscle injuryrhabdomyolysisstatin-associated autoimmune myopathy

Identifiers

PMID41994779
PMCPMC13081072

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.